The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China

Purpose-Immunotherapy has revolutionized cancer therapy, becoming the standard of care for various malignancy treatments. Human immunodeficiency virus (HIV) patients, however, are an underserved group with limited access to clinical trials and cancer therapy. This study was to evaluate the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Yu, Mo, Pingzheng, Yan, Yajun, Wang, Shan, Zhuang, Ke, Ma, Zhiyong, Chen, Xiaoping, Deng, Liping, Xiong, Yong, Deng, Di, Zhang, Yongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547588/
https://www.ncbi.nlm.nih.gov/pubmed/37799470
http://dx.doi.org/10.3389/fonc.2023.1248790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547588/
https://www.ncbi.nlm.nih.gov/pubmed/37799470
http://dx.doi.org/10.3389/fonc.2023.1248790

Ejemplares similares